Amundi’s Nutex Health NUTX Stock Holding History

Amundi’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$378K	Buy	+2,212	New	+$280K	﹤0.01%	1753
2023 Q1	–	Sell	-91	Closed	-$23K	–	2102
2022 Q4	$23K	Buy	+91	New	+$17.5K	﹤0.01%	1781

Other funds holding NUTX

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Amundi's NUTX Position: Q2 2026 in Review

Amundi opened a new position in Nutex Health (NUTX) in Q2 2026: 2,212 shares worth $378K. The stake represents ﹤0.01% of the portfolio and ranks #1753 among its holdings. This is a return to the name: Amundi previously reported a position in NUTX as recently as Q4 2022.

Amundi first reported a position in NUTX in Q4 2022 and has held it in 2 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

Amundi held 2,212 shares of Nutex Health worth $378K as of Q2 2026.
Nutex Health was a new Amundi position in Q2 2026.
Nutex Health made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1753 holding.
Amundi first reported a position in Nutex Health in Q4 2022 and has held it in 2 quarters since.
154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.